Delivery Order SPE2DB20D3303-SPE2DB24FA2DE

Award Date 8/16/24
Potential Completion Date 9/9/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $30,693.10 delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of CABOMETYX 40 MG TABLET 30S. The order is a firm fixed-price contract with a completion date of July 15, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,867.18 firm-fixed-price contract is for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product, with a period of performance through August 2024. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $14,346.44 firm fixed-price contract is for the delivery of CABOMETYX 40 MG TABLET 30S, a specialty medication, with a performance period through December 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a $15,346.55 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABOMETYX 40 MG TABLET 30S medication, with a performance period through July 15, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,908.27 firm-fixed-price contract is for the supply of CABOMETYX 60 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of November 13, 2024 and was awarded on October 22, 2024. There is no set-aside designation for this contract. AmerisourceBergen holds a significant $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Cabometyx 60 mg tablets. The contract has a ceiling value of $30,602.10 and a period of performance through May 29, 2025. It is a firm fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The $30,647.60 firm fixed price contract is for the delivery of CABOMETYX 40 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of July 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $28,692.88 delivery order contract is for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price and runs through January 9, 2025. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,346.44 firm fixed-price delivery order is for the supply of CABOMETYX 40 MG TABLET 30S, a specialty medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,301.05, is for the supply of CABOMETYX 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 21, 2025 and is a Firm Fixed Price contract. There is no set-aside designation indicated for this award. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA2DE
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $14,035.64 contract is for the supply of CABOMETYX 20 MG TABLET 30S, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military healthcare programs. Amerisourcebergen has also been awarded an IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar pharmaceutical and medical products. The contract does not have a set-aside designation.

Generated 11/15/24, 9:24 AM